NL-OMON45689已完成不适用
Secondary Manifestations of Arterial Disease - Influence of Cardiovascular Prognosis and Treatment Effect Predictions on Patient and Physician Decision-Making: a Three-armed, Blinded, Randomized Controlled Trial - SMART-INFORM
niversitair Medisch Centrum Utrecht0 个研究点目标入组 303 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 303
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Inclusion in the SMART study (NL45885.041.13)
- •2. Clinically manifest cardiovascular disease, such as a confirmed diagnosis or strong clinical suspicion of one of the following: coronary artery disease, cerebrovascular disease, peripheral artery disease.
- •3. Use of statin medication at baseline
- •4. 45-80 years of age
- •5. Rankin Scale <3
排除标准
- •1. Pregnancy
- •2. Terminal malignancy or short life-expectancy
- •3. No follow-up possible
- •4. Inability to effectively communicate in Dutch
- •5. No informed consent (IC) signed
- •6. Baseline questionnaire not returned
研究者
相似试验
招募中
不适用
SMART-INFORMNL-OMON27898niveristy Medical Center Utrecht264
尚未招募
不适用
Secondary Manifestations of ARTerial diseases in the Young with a chronic conditioatherosclerosiscardiovascular diseaseNL-OMON56581niversitair Medisch Centrum Utrecht1,350
已完成
不适用
Asymptomatic Peripheral Arterial Disease and Mortality in Patients on HemodialysisPatients who undergo maintenance hemodialysisJPRN-UMIN000020830Graduate school of medical sciences, kitasato university310
尚未招募
不适用
Cardiovascular disease manifestations in COVID-19 patientsCTRI/2021/06/034065Dr Swati Datta
Unknown
不适用
The effect of arterial disease level on the outcomes of supervised exercise in intermittent claudication: the ELECT RegistryNL-OMON27644Catharina Hospital Eindhoven320